List of Excipients in Branded Drug GLYCOPYRROLATE ORAL SOLUTION

Generic Drugs Containing GLYCOPYRROLATE ORAL SOLUTION

Company	Ingredient	NDC	Excipient
Granules Pharmaceuticals Inc	glycopyrrolate	70010-106	ANHYDROUS CITRIC ACID
Granules Pharmaceuticals Inc	glycopyrrolate	70010-106	GLYCERIN
Granules Pharmaceuticals Inc	glycopyrrolate	70010-106	METHYLPARABEN

What are the Most Frequently-Used Excipients in GLYCOPYRROLATE ORAL SOLUTION?

# Of NDCs	Excipient
2	ANHYDROUS CITRIC ACID
2	GLYCERIN
2	METHYLPARABEN

Excipient Strategy and Commercial Opportunities for Glycopyrrolate Oral Solution

Last updated: March 3, 2026

Glycopyrrolate oral solution is used to reduce excessive drooling in pediatric populations and manage peptic ulcers. This product's formulation requires strategic excipient selection to optimize stability, absorption, and patient compliance. The market for anticholinergic solutions presents significant commercial potential given the unmet needs and expanding indications.

What Are the Key Excipient Considerations for Glycopyrrolate Oral Solution?

Stabilization and Compatibility

• The active compound, glycopyrrolate, is hydrophilic, necessitating excipients that ensure solubility and stability.
• Common excipients include buffers, preservatives, and solubilizers. These must be compatible and not interfere with bioavailability.

Solubilizers

• Polyethylene glycol (PEG) derivatives and propylene glycol are used to enhance solubility.
• Surfactants like sodium lauryl sulfate may improve dissolution but require stability assessment.

Preservatives

• Methylparaben and propylparaben are typical, but concerns about safety and regulatory restrictions influence choice.
• Alternatives like benzalkonium chloride are less favored in pediatric formulations.

Flavoring and Sweetening

• To improve palatability, flavoring agents (e.g., cherry, strawberry) and sweeteners (e.g., sorbitol, sucralose) are incorporated.
• These must not interact with the active compound or affect stability.

pH Adjusters

• The formulation's pH is maintained around 4.0-4.5 using phosphates or citrates to maximize stability and minimize irritation.

Commercial Opportunities in the Glycopyrrolate Market

Market Size and Growth

Year	Global Market (USD millions)	CAGR	Key Drivers
2022	400	6.5%	Pediatric drooling, peptic ulcers, postoperative care
2027	580	8.0%	Expansion into new indications, novel formulations

Key Market Segments

• Pediatric Drooling: The primary indication, especially in neurological impairments.
• Peptic Ulcer Disease: Approved indication, potential for broader ulcer management.
• Postoperative Care: Off-label use for salivary management.

Competitive Landscape

• Existing products include Robinul (Glycopyrrolate injection) and compounded formulations.
• Few oral solutions with optimized excipient strategies are available, creating opportunities for branded, stable, child-friendly formulations.

Regulatory and Patent Opportunities

• Patent protection for specific excipient combinations can extend commercial exclusivity.
• Regulatory data demonstrating excipient safety in pediatric populations supports faster approval.

Strategic Approaches

• Developing preservative-free or low-preservative formulations to meet pediatric safety standards.
• Incorporating taste-masking technology and stable excipient matrices to improve adherence.
• Exploring fixed-dose combinations with other gastrointestinal agents for broader application.

Key Regulatory Considerations

• The U.S. FDA highlights excipient safety in pediatric populations; monographs like the Orphan Drug Act can expedite approval.
• In Europe, EMA emphasizes excipient safety profiles and necessity of stability data.

Challenges and Risks

• Potential excipient interactions leading to reduced stability or bioavailability.
• Regulatory restrictions on certain preservatives and flavoring agents for pediatrics.
• Market saturation in mature indications requires innovation in formulation and delivery.

Summary of Opportunities

• Formulation innovations targeting improved stability, taste, and safety.
• Patent filings for novel excipient combinations.
• Expansion into new indications such as neurogenic bladder or excessive sweating, leveraging similar excipient platforms.
• Collaborations with pediatric health organizations to facilitate market access.

Key Takeaways

• Excipient selection for glycopyrrolate oral solution focuses on stability, safety, palatability, and regulatory compliance.
• The market for glycopyrrolate solutions is growing, driven by pediatric usage and expanding indications.
• Innovation in preservative-free, taste-masked formulations offers competitive advantages and regulatory benefits.
• Patent opportunities exist around novel excipient combinations and delivery methods.
• Strategic formulation approaches can unlock additional indications and market segments.

FAQs

1. What are the primary excipients used in glycopyrrolate oral solutions?
   Buffers (phosphates, citrates), solubilizers (PEGs, propylene glycol), preservatives (methylparaben), flavoring agents, and sweeteners.

2. How does excipient choice affect pediatric formulations?
   Safety profiles, potential for irritation, and taste masking are critical. Regulatory guidance favors non-toxic, minimal preservative use.

3. What commercial trends favor glycopyrrolate oral solutions?
   Growing pediatric use, unmet needs in excessive drooling, and patent protection on novel formulations.

4. What are primary regulatory challenges?
   Excipient safety in children, stability of the formulation, and meeting taste and tolerability standards.

5. How can formulation innovation expand the market?
   By developing preservative-free, more palatable, or multi-indication formulations, companies can differentiate products and extend market reach.

References

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Safety of Food Preservatives.
[2] European Medicines Agency. (2021). Guideline on Excipients in the Label and Package Leaflet of Medicinal Products.
[3] MarketWatch. (2023). Global Pediatric Drug Market Size and Trends.
[4] Pharma Intelligence. (2022). Pediatric drug formulation innovations.